INTELLIGENT BIO SOLUTIONS INC. (INBS) Gross Margin
- Gross margin · 12 months: Value 48.63%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 48.63% | Gross profit / revenue. Period ending 2026-06-30. $2.05M ÷ $4.22M × 100 ≈ 48.63% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 2.05M USD | Gross Profit |
| Revenue | 4.22M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $2.05M | $4.22M | (m) | 48.63% |
| 2026-03-31 | $1.85M | $3.91M | (m) | 47.25% |
| 2025-12-31 | $1.65M | $3.58M | (m) | 46.21% |
| 2025-09-30 | $1.42M | $3.29M | (m) | 43.08% |
| 2025-06-30 | $1.25M | $3.05M | (m) | 40.85% |
| 2025-03-31 | $1.73M | $2.94M | (m) | 58.81% |
| 2024-12-31 | $1.56M | $3.03M | (m) | 51.59% |
| 2024-09-30 | $1.54M | $3.19M | (m) | 48.31% |
| 2024-06-30 | $1.43M | $3.11M | (m) | 45.81% |
| 2024-03-31 | $659.64K | $2.83M | (m) | 23.33% |
| 2023-12-31 | $514.20K | $2.46M | (m) | 20.90% |
| 2023-09-30 | $559.00K | $1.74M | (m) | 32.10% |
| 2023-06-30 | $326.67K | $1.26M | (m) | 25.99% |
| 2023-03-31 | (m) | $880.59K | (m) | (m) |
| 2022-12-31 | (m) | $616.03K | (m) | (m) |
| 2022-09-30 | (m) | $748.47K | (m) | (m) |
| 2022-06-30 | (m) | $437.15K | (m) | (m) |
| 2022-03-31 | (m) | $1.98M | (m) | (m) |
| 2021-12-31 | (m) | $1.82M | (m) | (m) |
| 2021-06-30 | (m) | $1.98M | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $188.74K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |